A recent study published in the Rheumatic and Musculoskeletal Diseases Open has highlighted the potential role of specific serum biomarker ratios in enhancing diagnostic accuracy …
A groundbreaking study published in International Immunopharmacology has revealed that serum levels of High Mobility Group Box Protein-1 (HMGB-1), a multifunctional protein, could serve as …
A recent clinical trial published in Alternative Therapies in Health and Medicines has highlighted the potential benefits of pirfenidone for treating nonspecific interstitial pneumonia (NSIP) …
Rheumatologists and researchers have long sought better biomarkers for diagnosing and predicting the progression of systemic sclerosis (SSc). A recent study has identified anti-protein arginine …
A long-term study published in Rheumatology (Oxford) has confirmed the efficacy of baricitinib in patients with moderate-to-severe rheumatoid arthritis (RA) who had inadequate responses to …
A post-hoc analysis of phase II and III trials published in the Journal of Rheumatology revealed that tofacitinib (TOF) was more effective than placebo in …
A recent multicenter, randomized clinical trial published in JAMA Network Open has highlighted the potential of mycophenolate mofetil (MMF) in reducing the risk of severe …
In a recent study published in Clinical Rheumatology, anti-α-1,4-D-polygalacturonic acid (PGA) antibodies have emerged as a promising biomarker for juvenile idiopathic arthritis (JIA), potentially reshaping …
A recent study published in Rheumatic and Musculoskeletal Diseases (RMD) Open has demonstrated the long-term safety and efficacy of ozoralizumab, a novel anti-TNF multivalent variable …